Role of deferoxamine on enzymatic stress markers in an animal model of Alzheimer's disease after chronic aluminum exposure

Biological Trace Element Research

Volumn 141, Issue 1-3, 2011, Pages 232-245

  Esparza, José L ^a   Garcia, Tania ^a   Gómez, Mercedes ^a   Nogués, M Rosa ^a   Giralt, Montserrat ^a   Domingo, José L ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Aluminum; Antioxidant enzymes; Deferoxamine; Gene expression; Oxidative stress; Tg2576 mice

Indexed keywords

ALUMINUM; AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; DEFEROXAMINE; GLUTATHIONE REDUCTASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CEREBELLUM; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HIPPOCAMPUS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WILD TYPE;

ALUMINUM; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BIOLOGICAL MARKERS; BRAIN; BRAIN CHEMISTRY; CHELATING AGENTS; DEFEROXAMINE; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; STRESS, PHYSIOLOGICAL;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 79959594585     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-010-8715-0     Document Type: Article

References (53)

1. Kawahara M (2005) Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. J Alzheimers Dis 8:171-182
2. Perl DP, Moalem S (2006) Aluminum and Alzheimer's disease, a personal perspective after 25 years. J Alzheimers Dis 9:291-300
3. Dua R, Gill KD (2001) Aluminium phosphide exposure: implications on rat brain lipid peroxidation and antioxidant defence system. Pharmacol Toxicol 89:315-319
4. Yousef MI (2004) Aluminium-induced changes in hemato-biochemical parameters, lipid peroxidation and enzyme activities of male rabbits: protective role of ascorbic acid. Toxicology 199:47-57
5. Bhalla P, Dhawan DK (2009) Protective role of lithium in ameliorating the aluminium-induced oxidative stress and histological changes in rat brain. Cell Mol Neurobiol 29:513-521
6. Behl C, Moosmann B (2002) Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach. Free Radic Biol Med 33:182-191
7. Gillette Guyonnet S, Andrieu S, Vellas B (2007) The potential influence of silica present in drinking water on Alzheimer's disease and associated disorders. J Nutr Health Aging 11:119-124
8. Rondeau V, Jacqmin-Gadda H, Commenges D, Helmer C, Dartigues JF (2009) Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am J Epidemiol 169:489-496
9. Shcherbatykh I, Carpenter DO (2007) The role of metals in the etiology of Alzheimer's disease. J Alzheimers Dis 11:191-205
10. Rohn TT, Rissman RA, Head E, Cotman CW (2002) Caspase activation in the Alzheimer's disease brain: tortuous and torturous. Drug News Perspect 15:549-557
11. Kaneko N, Yasui H, Takada J, Suzuki K, Sakurai H (2004) Orally administered aluminum-maltoate complex enhances oxidative stress in the organs of mice. J Inorg Biochem 98:2022-2031
12. Gupta VB, Anitha S, Hegde ML, Zecca L, Garruto RM, Ravid R, Shankar SK, Stein R, Shanmugavelu P, Jagannatha Rao KS (2005) Aluminum in Alzheimer's disease: are we still at a crossroad? Cell Mol Life Sci 62:143-158
13. Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, Niikura T, Hua F, Tsukagoshi-Nagai H, Horikoshi-Sakuraba Y, Mughal M, Rebeck GW, Laferla FM, Mattson MP, Iwata N, Saido TC, Klein WL, Duff KE, Aisen PS, Matsuoka Y (2008) Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res 1216:92-103
14. Wei YH, Lee HC (2002) Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes. Exp Biol Med 227:671-682
15. Esparza JL, Gómez M, Romeo M, Mulero M, Sanchez DJ, Mallol J, Domingo JL (2003) Aluminum-induced pro-oxidant effects in rats: protective role of exogenous melatonin. J Pineal Res 35:32-39
16. Esparza JL, Gómez M, Nogués MR, Paternain JL, Mallol J, Domingo JL (2005) Melatonin reduces oxidative stress and increases gene expression in the cerebral cortex and cerebellum of aluminum-exposed rats. J Pineal Res 39:129-136
17. Gómez M, Esparza JL, Nogues MR, Giralt M, Domingo JL (2005) Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration. Free Radic Biol Med 38:104-111
18. Lee HC, Wei YH (2007) Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Exp Biol Med 232:592-606
19. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23:134-147
20. De Felice FG, Vieira MN, Bomfim TR, Decker H, Velasco PT, Lambert MP, Viola KL, Zhao WQ, Ferreira ST, Klein WL (2009) Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci USA 106:1971-1976
21. GómezM, Esparza JL, Domingo JL, Singh PK, Jones MM (1998) Comparative aluminum mobilizing actions of deferoxamine and four 3-hydroxypyrid-4-ones in aluminum-loaded rats. Toxicology 130:175-181
22. Gómez M, Esparza JL, Domingo JL, Singh PK, Jones MM (1999) Chelation therapy in aluminum-loaded rats: influence of age. Toxicology 137:161-168
23. Esparza JL, Gómez M, Domingo JL, del Castillo D, Hernández M (2000) Age-related differences on aluminum mobilization by chelating agents in aluminum-loaded uraemic rats. Pharmacol Toxicol 87:33-38
24. Guelman LR (2004) Deferoxamine antioxidant activity on cerebellar granule cells γ-irradiated in vitro. Neurotoxicol Teratol 26:477-483
25. Schubert D, Soucek T, Blouw B (2009) The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide. Eur J Neurosci 29:1323-1334
26. Papazisis G, Pourzitaki C, Sardeli C, Lallas A, Amaniti E, Kouvelas D (2008) Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia-ischemia. Pharmacol Res 57:73-78
27. Valvassori SS, Petronilho FC, Réus GZ, Steckert AV, Oliveira VB, Boeck CR, Kapczinski F, Dal-Pizzol F, Quevedo J (2008) Effect of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania. Prog Neuropsychopharmacol Biol Psychiatry 32:1064-1088
28. Pratico D, Uryu K, Sung S, Tang S, Trojanowski JQ, Lee VMY (2002) Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J 16:1138-1140
29. Hidalgo A, Burgos V, Viola H, Medina J, Argibay P (2006) Differential expression of glycans in the hippocampus of rats trained on an inhibitory learning paradigm. Neuropathology 26:501-507
30. Maynard CJ, Cappai R, Volitakis I, Cherny RA, Masters CL, Li QX, Bush AI (2006) Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology. J Inorg Biochem 100:952-962
31. López-Toledano MA, Shelanski ML (2007) Increased neurogenesis in young transgenic mice overexpressing human APP (Sw, Ind). J Alzheimers Dis 12:229-240
32. Duyckaerts C, Poitier MC, Delatour B (2008) Alzheimer disease models and human neuropathology similarities and differences. Acta Neuropathol 115:5-38
33. Garcia T, Esparza JL, Nogués MR, Romeu M, Domingo JL, Gómez M (2010) Oxidative stress status and RNA expression in hippocampus of an animal model of Alzheimer's disease after chronic exposure to aluminium. Hippocampus 20:218-225
34. García T, Esparza JL, Giralt M, Romeu M, Domingo JL, Gómez M (2010) Protective role of melatonin on oxidative stress status and RNA expression in cerebral cortex and cerebellum of AbetaPP transgenic mice after chronic exposure to aluminum. Biol Trace Elem Res. doi:10.1007/s12011-009-8490-y
35. Drago D, Cavaliere A, Mascetra N, Ciavardelli D, Di Ilio C, Zatta P, Sensi SL (2008) Aluminum modulates effects of beta amyloid (1-42) on neuronal calcium homeostasis and mitochondria functioning and is altered in a triple transgenic mouse model of Alzheimer's disease. Rejuvenation Res 11:861-871
36. Gómez M, Esparza JL, Cabré M, García T, Domingo JL (2008) Aluminum exposure through the diet: metal levels in AβPP transgenic mice, a model for Alzheimer's disease. Toxicology 249:214-219
37. Ribes D, Colomina MT, Vicens P, Domingo JL (2008) Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer's disease. Exp Neurol 214:293-300
38. Golub MS, Germann SL, Keen CL (2003) Developmental aluminum toxicity in mice can be modulated by low concentrations of minerals (Fe, Zn, P, Ca, Mg) in the diet. Biol Trace Elem Res 93:213-226
39. Bradford MM (1976) A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
40. Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74:214-226
41. Wheeler C, Salzman J, Elsayed N (1990) Automated assays for superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase activity. Anal Biochem 184:193-199
42. ABI Prism 7700, Sequence detection system (1997) User Bulletin No. 2. Revision A. Foster City (CA): Applied Biosystems
43. Colomina MT, Roig JL, Sanchez DJ, Domingo JL (2002) Influence of age on aluminum-induced neurobehavioral effects and morphological changes in rat brain. Neurotoxicology 23:775-781
44. Golub MS, Germann SL, Han B, Keen CL (2000) Lifelong feeding of a high aluminum diet to mice. Toxicology 150:107-117
45. Yokel RA, Florence RL (2006) Aluminum bioavailability from the approved food additive leavening agent acid sodium aluminum phosphate, incorporated in to a baked good, is lower than from water. Toxicology 227:86-93
46. Luo Y, Nie J, Gong QH, Lu YF, Wu Q, Shi JS (2007) Protective effects of icariin against learning and memory deficits induced by aluminum in rats. Clin Exp Pharmacol Physiol 34:792-795
47. Candan N, Tuzmen N (2008) Very rapid quantification of malondialdehyde (MDA) in rat brain exposed to lead, aluminum and phenolic antioxidants by high-performance liquid chromatography-fluorescence detection. Neurotoxicology 29:708-713
48. Moumen R, Ait-Oukhata N, Bureau F, Fleury C, Bougle D, Arhan P, Neuville D, Viader F (2001) Aluminum increases xanthine oxidase activity and disturbs antioxidant status in the rat. J Trace Elem Med Biol 15:89-93
49. Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, Reiter RJ (2004) Regulation of antioxidant enzymes: a significant role for melatonin. A minireview. J Pineal Res 36:1-9
50. Youdim MB, Stephenson G, Ben Shachar D (2004) Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. N Y Acad Sci 1012:306-225
51. Mee-Jung P, Sang-Ki L, Mi-Ae L, Hee-Sun C, Sung-Ig C, Choon-Gon J, Lee S-M (2006) Effect of alphatocopherol and deferoxamine on methamphetamine-induced neurotoxicity. Brain Res 1109:176-182
52. Nicotera TM, Notaro J, Notaro S (1989) Elevate superoxide dismutase in Bloom's syndrome: a genetic condition of oxidative stress. Cancer Res 49:5239-5243
53. Yoo HY, Chang MS, Rho HM (1999) The activation of the rat copper/zinc superoxide dismutase gene by hydrogen peroxide through the hydrogen peroxide-responsive element and by paraquat and heat shock through the same heat shock element. J Biol Chem 23:887-892